Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "P01" (31)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Metronidazole (P01AB01) 13 products
WHO-DDD
DrugBank.ca
IP
CI
Flagyl 250 mg
20 Tablet(s)
4.01
13.55
10 %
Coated tablets: Metronidazolum 250 mg
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
IP
CI
Flagyl 500 mg
‐
I
-
T
4 Tablet(s)
1.51
10.85
10 %
Coated tablets: Metronidazolum 500 mg
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
IP
CI
Flagyl 500 mg
-
T
20 Tablet(s)
6.70
16.45
10 %
Coated tablets: Metronidazolum 500 mg
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
IP
CI
CM
Metronidazole Zentiva 250 mg
20 Tablet(s)
3.10
12.60
10 %
Coated tablets: Metronidazolum 250 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva 500 mg
4 Tablet(s)
1.22
10.55
10 %
Coated tablets: Metronidazolum 500 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva 500 mg
20 Tablet(s)
5.43
15.15
10 %
Coated tablets: Metronidazolum 500 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Metrolag 250 mg
20 Tablet(s)
3.02
12.50
10 %
Tablets: Metronidazolum 250 mg
Lagap SA
B / SL / SG
FB
G
IP
CI
Metrolag 500 mg
8 Tablet(s)
2.21
11.65
10 %
Tablets: Metronidazolum 500 mg
Lagap SA
B / SL / SG
FB
G
IP
CI
Metrolag 500 mg
24 Tablet(s)
6.52
16.30
10 %
Tablets: Metronidazolum 500 mg
Lagap SA
B / SL / SG
FB
G
IP
CI
Metrolag 250 mg
100 Tablet(s)
PR
PR
k.A.
Tablets: Metronidazolum 250 mg
Lagap SA
B
FB
G
IP
CI
Metrolag 500 mg
100 Tablet(s)
PR
PR
k.A.
Tablets: Metronidazolum 500 mg
Lagap SA
B
FB
G
CI
Rivozol 250 mg
20 Tablet(s)
PR
PR
k.A.
Tablets: Metronidazolum 250 mg
Rivopharm SA
B
FB
G
IP
CI
Rivozol
60 ml
PR
PR
k.A.
Suspension (oral): 2 Active Agents
Rivopharm SA
B
FB
G
Ornidazole (P01AB03) 3 products
WHO-DDD
IP
CI
Tiberal 500 mg
10 Tablet(s)
13.78
31.40
10 %
Coated tablets: Ornidazolum 500 mg
Curatis AG
B / SL
FB
G
IP
CI
Tiberal 1 g/6 mL
5 ampoule(s)
PR
PR
k.A.
Concentrate for infusion: Ornidazolum
Curatis AG
B
FB
G
IP
CI
Tiberal 500 mg/3 mL
5 ampoule(s)
PR
PR
k.A.
Concentrate for infusion: Ornidazolum 500mg / 3ml
Curatis AG
B
FB
G
Atovaquone (P01AX06) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
Wellvone
210 ml
432.15
486.40
10 %
Suspension: Atovaquonum 750mg / 5ml
GlaxoSmithKline AG
A / SL
FB
G
Hydroxychloroquine (P01BA02) 2 products
WHO-DDD
DrugBank.ca
L
IP
CI
Plaquenil
30 Tablet(s)
3.77
13.30
10 %
Coated tablets: Hydroxychloroquini Sulfas 200 mg
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
L
IP
CI
CM
Hydroxychloroquine
Zentiva
30 Tablet(s)
3.39
12.90
10 %
Coated tablets: Hydroxychloroquini Sulfas 200 mg
Helvepharm AG
B / SL / SG
FB
G
Proguanil and Atovaquone (P01BB51) 7 products
WHO-DDD
DrugBank.ca
L
IP
CI
Malarone
‐
I
-
T
12 Tablet(s)
22.30
40.55
10 %
Coated tablets: 2 Active Agents
GlaxoSmithKline AG
A / SL / SO
FB
G
L
IP
CI
Atovaquon-Proguanil-Mepha 250 / 100
12
20.30
38.50
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Atovaquone Plus Spirig HC
12 Tablet(s)
20.30
38.50
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
A / SL / SG
FB
G
IP
Atovaquon-Proguanil-Mepha
Junior 62.5 / 25
12
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
A
FB
G
IP
CI
Atovaquon-Proguanil-Mepha 250 / 100
24
PR
PR
k.A.
Coated tablets: 2 Active Agents
Mepha Pharma AG
A
FB
G
IP
CI
Atovaquone Plus Spirig HC
24
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
A
FB
G
IP
CI
Malarone Junior
12
PR
PR
k.A.
Coated tablets: 2 Active Agents
GlaxoSmithKline AG
A
FB
G
Mefloquine (P01BC02) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Mephaquin
‐
I
8 Tablet(s)
PR
PR
k.A.
Coated tablets: Mefloquinum 250 mg
Mepha Pharma AG
A
FB
G
Pyrimethamine (P01BD01) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
Daraprim
-
T
30
13.48
31.10
10 %
Tablets: Pyrimethaminum 25 mg
GlaxoSmithKline AG
B / SL
FB
G
Artemether and Lumefantrine (P01BF01) 2 products
WHO-DDD
DrugBank.ca
L
IP
CI
Riamet 20 mg/120 mg
24 Tablet(s)
25.94
44.65
10 %
Tablets: 2 Active Agents
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Riamet Dispersible
12
12.97
30.50
10 %
Tablets: 2 Active Agents
Novartis Pharma
Schweiz AG
A / SL
FB
G
Pentamidine Isethionate (P01CX01) 1 products
WHO-DDD
IP
CI
Pentacarinat
5 ampoule(s)
152.53
182.30
10 %
substance sèche pour solution à injection ou à inhalation: Pentamidini Diisethionas 300 mg
Future Health Pharma
GmbH
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home